Dashboard
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Poor long term growth as Net Sales has grown by an annual rate of 24.92% and Operating profit at 9.69% over the last 5 years
4
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.92%
0%
5.92%
6 Months
-2.72%
0%
-2.72%
1 Year
-18.93%
0%
-18.93%
2 Years
-21.96%
0%
-21.96%
3 Years
-58.6%
0%
-58.6%
4 Years
-43.07%
0%
-43.07%
5 Years
-52.69%
0%
-52.69%
Xi'an International Medical Investment Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.92%
EBIT Growth (5y)
9.69%
EBIT to Interest (avg)
-2.86
Debt to EBITDA (avg)
27.30
Net Debt to Equity (avg)
1.17
Sales to Capital Employed (avg)
0.54
Tax Ratio
5.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.33%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.14
EV to EBIT
-57.22
EV to EBITDA
32.26
EV to Capital Employed
1.98
EV to Sales
3.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.45%
ROE (Latest)
-12.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
961.10
1,185.80
-18.95%
Operating Profit (PBDIT) excl Other Income
-107.90
124.10
-186.95%
Interest
33.50
40.30
-16.87%
Exceptional Items
-8.90
30.30
-129.37%
Consolidate Net Profit
-155.70
-65.40
-138.07%
Operating Profit Margin (Excl OI)
-112.20%
-53.10%
-5.91%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -18.95% vs 6.23% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -138.07% vs -463.79% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
4,815.30
4,547.70
5.88%
Operating Profit (PBDIT) excl Other Income
544.90
453.60
20.13%
Interest
181.30
348.20
-47.93%
Exceptional Items
25.40
1.30
1,853.85%
Consolidate Net Profit
-365.10
-471.90
22.63%
Operating Profit Margin (Excl OI)
-41.60%
-72.60%
3.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 5.88% vs 70.17% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 22.63% vs 60.52% in Dec 2023
About Xi'an International Medical Investment Co., Ltd. 
Xi'an International Medical Investment Co., Ltd.
Hospital
No Details Available.
Company Coordinates 
No Company Details Available






